These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 8413382)

  • 21. "Seronegative" anti-MUSK positive myasthenia gravis presenting during pregnancy.
    Terrero A; Ramírez-Rivera J
    Bol Asoc Med P R; 2006; 98(3):210-2. PubMed ID: 19610560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. On the mechanism of pathogenesis of human myasthenia gravis.
    Roses AD; Hudgson P; McAdams MW; Edwards AM; Olanow CW
    Trans Am Neurol Assoc; 1981; 106():212-5. PubMed ID: 7348997
    [No Abstract]   [Full Text] [Related]  

  • 23. Antibody to acetylcholine receptors increases the turnover of acetylcholine receptor: clinical relevance and mechanism of action.
    Clementi F; Conti Tronconi B; Fumagalli G; Pelloja F; Sher E; Sinigaglia F; Villa A
    Ann Ist Super Sanita; 1982; 18(1):69-74. PubMed ID: 7171175
    [No Abstract]   [Full Text] [Related]  

  • 24. Anti-MuSK myasthenia gravis presenting with purely ocular findings.
    Caress JB; Hunt CH; Batish SD
    Arch Neurol; 2005 Jun; 62(6):1002-3. PubMed ID: 15956173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MuSK-antibody positive myasthenia gravis: questions from the clinic.
    Sanders DB; Juel VC
    J Neuroimmunol; 2008 Sep; 201-202():85-9. PubMed ID: 18684517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Musk-antibody positive myasthenia gravis presenting with isolated neck extensor weakness.
    Casasnovas C; Povedano M; Jaumà S; Montero J; Martínez-Matos JA
    Neuromuscul Disord; 2007 Jul; 17(7):544-6. PubMed ID: 17533129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High interleukin-10 production is associated with anti-acetylcholine receptor antibody production and treatment response in juvenile myasthenia gravis.
    Yapici Z; Tüzün E; Altunayoğlu V; Erdoğan A; Eraksoy M
    Int J Neurosci; 2007 Nov; 117(11):1505-12. PubMed ID: 17917921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MuSK antibody-positive, seronegative myasthenia gravis in Korea.
    Lee JY; Sung JJ; Cho JY; Oh DH; Kim HJ; Park JH; Lee KW; Choi YC; Vincent A
    J Clin Neurosci; 2006 Apr; 13(3):353-5. PubMed ID: 16546389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Anesthetic considerations for thymectomy in a patient having an anti-acetylcholine receptor antibody without myasthenia gravis].
    Koshida T; Hara K; Obara G; Sata T
    Masui; 2008 Aug; 57(8):993-5. PubMed ID: 18710007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myasthenia gravis. Antibodies to skeletal muscle cell surface antigens.
    Gilhus NE; Aarli JA; Matre R
    J Neuroimmunol; 1983 Dec; 5(3):239-49. PubMed ID: 6361067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of human anti-acetylcholine receptor monoclonal autoantibodies from the peripheral blood of a myasthenia gravis patient using combinatorial libraries.
    Rey E; Zeidel M; Rhine C; Tami J; Krolick K; Fischbach M; Sanz I
    Clin Immunol; 2000 Sep; 96(3):269-79. PubMed ID: 10964546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isolation and functional characterization of anti-acetylcholine receptor subunit-specific autoantibodies from myasthenic patients: receptor loss in cell culture.
    Sideris S; Lagoumintzis G; Kordas G; Kostelidou K; Sotiriadis A; Poulas K; Tzartos SJ
    J Neuroimmunol; 2007 Sep; 189(1-2):111-7. PubMed ID: 17617475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serological follow-up in juvenile myasthenia: clinical and acetylcholine receptor antibody status of patients followed for at least 2 years.
    Anlar B; Senbil N; Köse G; Değerliyurt A
    Neuromuscul Disord; 2005 May; 15(5):355-7. PubMed ID: 15833428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibody detection in MG.
    Seybold ME; Lindstrom JM
    Neurology; 1981 Jun; 31(6):781-3. PubMed ID: 7195500
    [No Abstract]   [Full Text] [Related]  

  • 35. Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis.
    Shiraishi H; Motomura M; Yoshimura T; Fukudome T; Fukuda T; Nakao Y; Tsujihata M; Vincent A; Eguchi K
    Ann Neurol; 2005 Feb; 57(2):289-93. PubMed ID: 15668981
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Muscle-specific kinase (MuSK) antibody-associated myasthenia gravis after bone marrow transplantation.
    Atassi N; Amato AA
    Muscle Nerve; 2008 Aug; 38(2):1074-5. PubMed ID: 18537145
    [No Abstract]   [Full Text] [Related]  

  • 37. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
    Cole RN; Reddel SW; Gervásio OL; Phillips WD
    Ann Neurol; 2008 Jun; 63(6):782-9. PubMed ID: 18384168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unravelling the pathogenesis of myasthenia gravis.
    Vincent A
    Nat Rev Immunol; 2002 Oct; 2(10):797-804. PubMed ID: 12360217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical fluctuations in MuSK myasthenia gravis are related to antigen-specific IgG4 instead of IgG1.
    Niks EH; van Leeuwen Y; Leite MI; Dekker FW; Wintzen AR; Wirtz PW; Vincent A; van Tol MJ; Jol-van der Zijde CM; Verschuuren JJ
    J Neuroimmunol; 2008 Mar; 195(1-2):151-6. PubMed ID: 18384886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG.
    Leite MI; Ströbel P; Jones M; Micklem K; Moritz R; Gold R; Niks EH; Berrih-Aknin S; Scaravilli F; Canelhas A; Marx A; Newsom-Davis J; Willcox N; Vincent A
    Ann Neurol; 2005 Mar; 57(3):444-8. PubMed ID: 15732104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.